▶ 調査レポート

世界の細胞アッセイ市場2022年-2027年:成長・動向・新型コロナの影響・市場予測

• 英文タイトル:Cell-Based Assay Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Cell-Based Assay Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)「世界の細胞アッセイ市場2022年-2027年:成長・動向・新型コロナの影響・市場予測」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2203A157
• 出版社/出版日:Mordor Intelligence / 2022年1月
• レポート形態:英文、PDF、120ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥703,000 (USD4,750)▷ お問い合わせ
  Site Licence¥962,000 (USD6,500)▷ お問い合わせ
  Corporate License¥1,295,000 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Mordor Intelligence社の本市場調査レポートでは、世界の細胞アッセイ市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別(細胞株、試薬・キット、マイクロプレート、その他消耗品)分析、技術別(自動ハンドリング、フローサイトメトリー、ラベルフリー検出、ハイスループットスクリーニング、その他)分析、用途別(創薬、その他)分析、エンドユーザー別(学術・政府機関、製薬・バイオテクノロジー企業、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・世界の細胞アッセイ市場規模:製品別(細胞株、試薬・キット、マイクロプレート、その他消耗品)
・世界の細胞アッセイ市場規模:技術別(自動ハンドリング、フローサイトメトリー、ラベルフリー検出、ハイスループットスクリーニング、その他)
・世界の細胞アッセイ市場規模:用途別(創薬、その他)
・世界の細胞アッセイ市場規模:エンドユーザー別(学術・政府機関、製薬・バイオテクノロジー企業、その他)
・世界の細胞アッセイ市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)
・競争状況(Becton, Dickinson and Company、Bio-Rad Laboratories, Inc.、Corning Inc.、…)
・市場機会・将来傾向

The cell-based assay market will show rapid growth due to the rising prevalence of chronic diseases and lifestyle disorders, increasing investments in R&D for drug discovery and the rise in technological advancements in cell-based methodologies.

The rising prevalence of chronic diseases and lifestyle disorders, such as cancer, cardiovascular, diabetes, and neurological disorders is one of the primary factors fueling the market growth. According to the WHO, chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the United States. It has been calculated that, in 2001, chronic diseases contributed approximately 60% of the 56.5 million total reported deaths in the world and approximately 46% of the global burden of disease. The proportion of the burden of NCDs is expected to increase to 57% by 2020.

Almost half of the total chronic disease deaths are attributable to cardiovascular diseases, obesity and diabetes are also showing increasing trends. Thus, the rise in chronic diseases leads to demand growth for cell-based assays for new drug discoveries, making it a vital factor for market growth. In addition, the demand for cell-based assay has increased significantly owing to a surge in cell-based applications in drug discovery and the rise in technological advancements in cell-based assays methodologies.

Key Market Trends

Drug Discovery is Expected to be the Largest Growing Segment Under Application in the Cell-Based Assay Market

The drug discovery segment is anticipated to show high growth in the market and this growth can be attributed to the increase in the R&D investment by biopharmaceutical companies. In addition, the rise in the prevalence of chronic diseases, such as cancer, osteoarthritis, cardiovascular diseases, and diabetes, is fueling the demand for cell-based assays for newer drug discoveries, making it a vital factor for the growth of this market. In cell-based assays, functional cells are used as diagnostic tools in research for new drugs that help in drug discovery.

North America is Found Leading the Cell-Based Assay Market

North America is the leading region across the world in terms of market share owing to the well-established healthcare sector along with the high adoption of cell-based therapies. In the United States, the prevalence of chronic diseases, such as cancer, osteoarthritis, and diabetes, is increasing that is fueling the demand for cell-based assays for newer drug discoveries, making it a vital factor for the growth of this market.

Asia Pacific is expected to register the highest CAGR in the market during the forecast period. Growth in the APAC region is largely driven by the increasing R&D investment by the government and increasing infrastructural development in the region.

Competitive Landscape

The key players operating in the global cell-based assay market are Becton, Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific, Inc., General Electric Company, Merck KGaA, Perkinelmer, Inc., Bio-Rad Laboratories, Inc., and Promega Corporation. Product innovation and ongoing R&D activities to develop advanced technologies have helped in boosting the growth of the market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
レポート目次

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Chronic Diseases and Lifestyle Disorders
4.2.2 Increasing Investments in R&D for Drug Discovery
4.2.3 Rise in Technological Advancements in Cell-based Methodologies
4.3 Market Restraints
4.3.1 High Maintenance and Operational Costs
4.3.2 Lack of Skilled Personnel to Operate these Technologies
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Cell Lines
5.1.1.1 Primary Cell Lines
5.1.1.2 Stem Cell Lines
5.1.1.3 Others
5.1.2 Reagents and Kits
5.1.3 Microplates
5.1.4 Other Consumables
5.2 By Technology
5.2.1 Automated Handling
5.2.2 Flow Cytometry
5.2.3 Label-free Detection
5.2.4 High-throughput Screening
5.2.5 Others
5.3 By Application
5.3.1 Drug Discovery
5.3.2 Other Applications
5.4 By End-user
5.4.1 Academic & Government Institutes
5.4.2 Pharmaceutical and Biotechnology Companies
5.4.3 Others
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle-East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Becton, Dickinson and Company
6.1.2 Bio-Rad Laboratories, Inc.
6.1.3 Corning Inc.
6.1.4 Danaher Corporation
6.1.5 Thermo Fisher Scientific Inc.
6.1.6 F. Hoffmann-La Roche Ltd
6.1.7 Merck KGaA
6.1.8 Perkin Elmer Inc.
6.1.9 Promega Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS